Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection ; volume:49 ; number:5 ; day:15 ; month:2 ; year:2024 ; pages:770-771 ; date:4.2024
Neuropsychopharmacology ; 49, Heft 5 (15.2.2024), 770-771, 4.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41386-024-01815-4
- URN
-
urn:nbn:de:101:1-2405210850026.517315544356
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frye, Mark A.
- Nemeroff, Charles B.
- SpringerLink (Online service)
Other Objects (12)
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Comprehensive pharmacogenomic characterization of gastric cancer
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
In silico comparative characterization of pharmacogenomic missense variants
Implementing pharmacogenomic clinical decision support into German hospitals
Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
Systematic identification of non-coding pharmacogenomic landscape in cancer
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Comprehensive pharmacogenomic characterization of gastric cancer
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
In silico comparative characterization of pharmacogenomic missense variants
Implementing pharmacogenomic clinical decision support into German hospitals
Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review
Systematic identification of non-coding pharmacogenomic landscape in cancer
Pharmacogenomic testing for antidepressant treatment selection: lessons learned and roadmap forward
Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder
Comprehensive pharmacogenomic characterization of gastric cancer
Pharmacogenomic biomarkers as source of evidence of the effectiveness and safety of antidepressant therapy
A Landscape of Pharmacogenomic Interactions in Cancer
GDSCTools for Mining Pharmacogenomic Interactions in Cancer
Identification of Pharmacogenomic and Functional Biomarkers for Antidepressant Treatment Outcome in Patients-Derived Lymphoblastoid Cell Lines
In silico comparative characterization of pharmacogenomic missense variants
Implementing pharmacogenomic clinical decision support into German hospitals
Discordancy Partitioning for Validating Potentially Inconsistent Pharmacogenomic Studies
Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review